









Mercado
/
Acciones
/
nasdaq-a
/

Agilent Technologies Inc

133.270USD

-0.600-0.45%

Cierre 01/29, 16:00（ET）Cotizaciones retrasadas 15 min

37.72BCap. mercado

29.05P/E TTM



Agilent Technologies Inc

133.270

-0.600-0.45%

Descripción general Compañía Finanzas Análisis

Descripción general

Compañía

Finanzas

Análisis

Más Datos de Agilent Technologies Inc Compañía

Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.

Información de Agilent Technologies Inc



Símbolo de cotizaciónA

Nombre de la empresaAgilent Technologies Inc

Fecha de salida a bolsaNov 18, 1999

Director ejecutivoMcdonnell (Padraig)

Número de empleados- -

Tipo de seguridadOrdinary Share

Fin del año fiscalNov 18

Dirección5301 Stevens Creek Blvd

CiudadSANTA CLARA

Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE

PaísUnited States of America

Código postal95051

Teléfono14083458886

Sitio Webhttps://www.agilent.com/

Símbolo de cotizaciónA

Fecha de salida a bolsaNov 18, 1999

Director ejecutivoMcdonnell (Padraig)

Ejecutivos de Agilent Technologies Inc



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Boon Hwee Koh

Non-Executive Independent Chairman of the Board

61.55K

+1273.00%

Mr. Rodney Gonsalves

Vice President, Corporate Controller, Principal Accounting Officer

48.88K

+426.00%

Dr. George A. Scangos, Ph.D.

Independent Director

38.35K

+1819.00%

Dr. Daniel K. Podolsky, M.D.

Independent Director

35.68K

Mr. Dow R. Wilson

Independent Director

18.04K

+1819.00%

Ms. Mala Anand

Independent Director

14.55K

+1819.00%

Dr. Simon May

Senior Vice President, Agilent President, Life Sciences and Diagnostics Markets Group

13.80K

+6481.00%

Mr. Adam Stewart Elinoff

Chief Financial Officer, Senior Vice President

11.73K

+11726.00%

Dr. Otis W. Brawley, M.D.

Independent Director

10.73K

+2631.00%

Dr. Mikael G. Dolsten, M.D., Ph.D.

Independent Director

4.95K

-2600.00%

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Boon Hwee Koh

Non-Executive Independent Chairman of the Board

61.55K

+1273.00%

Mr. Rodney Gonsalves

Vice President, Corporate Controller, Principal Accounting Officer

48.88K

+426.00%

Dr. George A. Scangos, Ph.D.

Independent Director

38.35K

+1819.00%

Dr. Daniel K. Podolsky, M.D.

Independent Director

35.68K

Mr. Dow R. Wilson

Independent Director

18.04K

+1819.00%

Ms. Mala Anand

Independent Director

14.55K

+1819.00%

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

FY2018

Por negocioUSD

Nombre

Ganancia

Proporción

Non-instrumentation and other

4.52B

65.07%

Instrumentation

2.43B

34.93%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

2.81B

40.39%

Asia Pacific

2.22B

31.94%

Europe

1.92B

27.68%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Non-instrumentation and other

4.52B

65.07%

Instrumentation

2.43B

34.93%

Estadísticas de accionistas

Actualizado: dom., 16 de nov

Accionistas

Tipos de accionistas

Accionistas

Proporción

The Vanguard Group, Inc.

11.98%

BlackRock Institutional Trust Company, N.A.

5.27%

MFS Investment Management

4.64%

State Street Investment Management (US)

4.39%

Wellington Management Company, LLP

3.31%

Otro

70.40%

Accionistas

Proporción

The Vanguard Group, Inc.

11.98%

BlackRock Institutional Trust Company, N.A.

5.27%

MFS Investment Management

4.64%

State Street Investment Management (US)

4.39%

Wellington Management Company, LLP

3.31%

Otro

70.40%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

43.87%

Investment Advisor/Hedge Fund

37.06%

Hedge Fund

3.06%

Research Firm

1.88%

Pension Fund

1.84%

Insurance Company

1.67%

Bank and Trust

1.43%

Sovereign Wealth Fund

1.23%

Family Office

0.44%

Otro

7.52%

Participación institucional



Actualizado: lun., 8 de dic

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q4

2057

261.01M

94.90%

-134.75K

2025Q3

2120

261.17M

95.32%

-153.68K

2025Q2

2118

261.09M

93.90%

+1.73M

2025Q1

2146

261.16M

94.63%

-8.63M

2024Q4

2129

260.37M

94.60%

-340.38K

2024Q3

2073

260.94M

95.43%

-3.57M

2024Q2

2043

263.64M

96.52%

-5.86M

2024Q1

2043

270.13M

95.69%

-10.33M

2023Q4

2063

269.78M

93.21%

+5.05M

2023Q3

1993

263.26M

94.34%

-4.53M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

The Vanguard Group, Inc.

33.91M

11.96%

+39.32K

+0.12%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

14.95M

5.27%

+91.77K

+0.62%

Sep 30, 2025

MFS Investment Management

11.51M

4.06%

-681.27K

-5.59%

Sep 30, 2025

State Street Investment Management (US)

12.44M

4.39%

-12.77K

-0.10%

Sep 30, 2025

Wellington Management Company, LLP

9.38M

3.31%

+433.34K

+4.84%

Sep 30, 2025

T. Rowe Price Investment Management, Inc.

8.15M

2.87%

-13.65K

-0.17%

Sep 30, 2025

Geode Capital Management, L.L.C.

7.40M

2.61%

+81.19K

+1.11%

Sep 30, 2025

Generation Investment Management LLP

6.36M

2.24%

+582.09K

+10.08%

Sep 30, 2025

Pictet Asset Management Ltd.

5.26M

1.85%

+485.39K

+10.17%

Sep 30, 2025

DWS Investment GmbH

4.55M

1.6%

+741.64K

+19.48%

Sep 30, 2025

ETFs relacionados



Actualizado: sáb., 6 de dic

Nombre

Proporción

Honeytree US Equity ETF

5.06%

First Trust Water ETF

4.76%

Goldman Sachs Future Health Care Equity ETF

3.87%

VanEck Morningstar Wide Moat Value ETF

3.31%

Madison Covered Call ETF

3.27%

iShares Health Innovation Active ETF

2.9%

VanEck Morningstar Wide Moat ETF

2.87%

Argent Mid Cap ETF

2.57%

Global X Genomics & Biotechnology ETF

2.4%

Invesco Zacks Mid-Cap ETF

2.29%

Honeytree US Equity ETF

Proporción5.06%

First Trust Water ETF

Proporción4.76%

Goldman Sachs Future Health Care Equity ETF

Proporción3.87%

VanEck Morningstar Wide Moat Value ETF

Proporción3.31%

Madison Covered Call ETF

Proporción3.27%

iShares Health Innovation Active ETF

Proporción2.9%

VanEck Morningstar Wide Moat ETF

Proporción2.87%

Argent Mid Cap ETF

Proporción2.57%

Global X Genomics & Biotechnology ETF

Proporción2.4%

Invesco Zacks Mid-Cap ETF

Proporción2.29%

Dividendos



Un total de 1.31B USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Nov 19, 2025

A.NB Interim Cash Dividend of gross USD 0.255 paid on Jan 28, 2026 going ex on Jan 06, 2026 with reinvestment option

Jan 06, 2026

Jan 28, 2026

Jan 06, 2026

Sep 17, 2025

A.NB Final Cash Dividend of gross USD 0.248 paid on Oct 22, 2025 going ex on Sep 30, 2025 with reinvestment option

Sep 30, 2025

Oct 22, 2025

Sep 30, 2025

May 21, 2025

A.NB Interim Cash Dividend of gross USD 0.248 paid on Jul 23, 2025 going ex on Jul 01, 2025 with reinvestment option

Jul 01, 2025

Jul 23, 2025

Jul 01, 2025

Feb 19, 2025

A.NB Interim Cash Dividend of gross USD 0.248 paid on Apr 23, 2025 going ex on Apr 01, 2025 with reinvestment option

Apr 01, 2025

Apr 23, 2025

Apr 01, 2025

Nov 20, 2024

A.NB Interim Cash Dividend of gross USD 0.248 paid on Jan 22, 2025 going ex on Dec 31, 2024 with reinvestment option

Dec 31, 2024

Jan 22, 2025

Dec 31, 2024

Sep 18, 2024

A.NB Final Cash Dividend of gross USD 0.236 paid on Oct 23, 2024 going ex on Oct 01, 2024 with reinvestment option

Oct 01, 2024

Oct 23, 2024

Oct 01, 2024

May 22, 2024

A.NB Interim Cash Dividend of gross USD 0.236 paid on Jul 24, 2024 going ex on Jul 02, 2024

Jul 02, 2024

Jul 24, 2024

Jul 02, 2024

Feb 21, 2024

A.NB Interim Cash Dividend of gross USD 0.236 paid on Apr 24, 2024 going ex on Apr 01, 2024

Apr 02, 2024

Apr 24, 2024

Apr 01, 2024

Nov 16, 2023

A.NB Interim Cash Dividend of gross USD 0.236 paid on Jan 24, 2024 going ex on Dec 29, 2023

Jan 02, 2024

Jan 24, 2024

Dec 29, 2023

Sep 21, 2023

A.NB Final Cash Dividend of gross USD 0.225 paid on Oct 25, 2023 going ex on Oct 02, 2023 with reinvestment option

Oct 03, 2023

Oct 25, 2023

Oct 02, 2023

División de acciones



Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

KeyAI

